Can arthritis increase the risk of osteoporosis? 

Yes, there is a significant link between inflammatory arthritis and the development of osteoporosis. While arthritis affects the joints, it is a systemic condition that can have a profound impact on the structural integrity of the entire skeleton. In the UK, bone health monitoring is a standard part of long-term care for conditions like Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA). Understanding this relationship is vital for preventing fractures and maintaining independence as you manage your arthritis. 

What We’ll Discuss in This Article 

• The biological link: How inflammation breaks down bone tissue 

• The role of arthritis medications in bone loss 

• How reduced mobility and “disuse” impact bone density 

• Specific arthritis types with the highest risk of osteoporosis 

• UK screening standards and DEXA scans for arthritis patients 

• Strategies to protect your bones while managing joint inflammation 

Inflammatory arthritis increases the risk of osteoporosis through three primary pathways: the direct effect of inflammatory chemicals on bone cells, the side effects of certain medications (specifically corticosteroids), and the reduced physical activity that often accompanies joint pain. The NHS notes that people with rheumatoid arthritis are at a higher risk of developing osteoporosis due to both the condition itself and the medications used to treat it. 

How Inflammation Affects Bone Density 

In a healthy body, bone is a living tissue that is constantly being broken down and rebuilt. This process is managed by two types of cells: osteoclasts (which remove old bone) and osteoblasts (which build new bone). 

In inflammatory arthritis, the body releases high levels of proteins called cytokines (such as TNF-alpha and IL-6). These cytokines overstimulate the osteoclasts, causing bone to be broken down faster than it can be replaced.⁴ This doesn’t just happen at the site of the inflamed joint; these chemicals travel through the bloodstream, leading to generalized bone thinning across the entire body. 

The Impact of Medication 

The most significant medication-related risk comes from the use of corticosteroids, such as prednisolone. While these are excellent for stopping an arthritis flare, long-term use is a leading cause of secondary osteoporosis. 

Calcium Absorption

Steroids reduce the amount of calcium the body absorbs from food.

Bone Building

They directly inhibit the activity of bone-building osteoblasts.

Hormonal Balance

Long-term use can disrupt hormones that are essential for maintaining bone mass in both men and women.

The National Institute for Health and Care Excellence (NICE) provides clear guidelines on assessing and treating bone health for anyone expected to be on oral steroids for more than three months. 

“Disuse” and Reduced Mobility 

Bone density is heavily influenced by “loading”, the physical stress placed on bones through walking, running, and weight-bearing exercise. When arthritis makes movement painful, many people become less active. This lack of weight-bearing activity signals to the body that the bones do not need to be as strong, leading to a further decrease in density. This creates a challenging cycle: joint pain leads to inactivity, which leads to weaker bones, which increases the risk of a fracture if a fall occurs. 

Comparison: Arthritis Types and Bone Risk 

Arthritis Type	Primary Osteoporosis Driver	Risk Level
Rheumatoid Arthritis	High systemic inflammation + steroids	Very High
Psoriatic Arthritis	Systemic inflammation	High
Ankylosing Spondylitis	Spinal inflammation and stiffness	High (risk of spinal fracture)
Osteoarthritis	Mostly localized; less systemic risk	Low (linked to age/immobility)
Lupus (SLE)	Chronic inflammation + high steroid use	High

Screening and Prevention in the UK 

If you have inflammatory arthritis, your clinical team will likely monitor your bone health through a FRAX assessment (a tool used to calculate fracture risk) and potentially a DEXA scan, which measures bone mineral density. 

The Royal Osteoporosis Society recommends several strategies for people with arthritis to protect their bones. 

Target Remission

Controlling the underlying arthritis inflammation is the most effective way to stop systemic bone loss.

Nutrition

Ensuring an adequate intake of Calcium and Vitamin D. In the UK, many arthritis patients are prescribed a daily supplement.

Weight-Bearing Exercise

Activities like brisk walking or strength training, as tolerated by your joints.

Bone-Protecting Drugs

If your risk is high, you may be prescribed bisphosphonates (like alendronate) to strengthen your bones.

Conclusion 

The link between arthritis and osteoporosis is well-established, but it is not inevitable. By managing your joint inflammation effectively, staying as active as possible, and working with your GP to monitor your bone density, you can significantly reduce your risk of fractures. Bone health is an integral part of holistic arthritis management. If you experience sudden, severe back pain or an inability to bear weight after a minor fall, call 999 or seek urgent medical attention immediately. 

Authority Snapshot (E-E-A-T Block) 

This evidence-based guide follows UK clinical standards for both rheumatology and bone health, drawing from the NHS, NICE, and the Royal Osteoporosis Society. The content is authored by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine and emergency care. Our goal is to provide safe, factual, and practical information to help the public manage the systemic health implications of autoimmune conditions.